HF
MDGL icon

HRT Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

HRT Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4M Buy
+84,634
New +$43.4M 0.08% 219
2026
Q1 		– Sell
-4,218
Closed -$2.02M – 4351
2025
Q4 		$2.46M Buy
+4,218
New +$2.15M 0.01% 1176
2025
Q1 		– Sell
-12,588
Closed -$3.88M – 3034
2024
Q4 		$3.88M Buy
12,588
+2,500
+25% +$703K 0.02% 476
2024
Q3 		$2.14M Buy
+10,088
New +$2.58M 0.01% 860
2024
Q1 		– Sell
-3,716
Closed -$859K – 2777
2023
Q4 		$859K Buy
+3,716
New +$650K 0.01% 1068
2023
Q2 		– Sell
-13,270
Closed -$3.21M – 2932
2023
Q1 		$3.21M Buy
13,270
+2,351
+22% +$641K 0.04% 408
2022
Q4 		$3.17M Buy
+10,919
New +$1.07M 0.04% 403
2022
Q1 		– Sell
-9,589
Closed -$812K – 3545
2021
Q4 		$812K Buy
+9,589
New +$788K ﹤0.01% 1301
2021
Q3 		– Sell
-10,759
Closed -$1.05M – 3571
2021
Q2 		$1.05M Buy
+10,759
New +$1.27M 0.01% 1020
2020
Q4 		– Sell
-7,019
Closed -$833K – 2200
2020
Q3 		$833K Buy
+7,019
New +$762K 0.02% 656
2019
Q4 		– Sell
-4,217
Closed -$363K – 1453
2019
Q3 		$363K Buy
+4,217
New +$396K 0.02% 831

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HRT Financial's MDGL Position: Q2 2026 in Review

HRT Financial opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 84,634 shares worth $45.4M. The stake represents 0.08% of the portfolio and ranks #219 among its holdings. This is a return to the name: HRT Financial previously reported a position in MDGL as recently as Q4 2025.

HRT Financial first reported a position in MDGL in Q3 2019 and has held it in 11 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • HRT Financial held 84,634 shares of Madrigal Pharmaceuticals worth $45.4M as of Q2 2026.
  • Madrigal Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.08% of HRT Financial's portfolio in Q2 2026, its #219 holding.
  • HRT Financial first reported a position in Madrigal Pharmaceuticals in Q3 2019 and has held it in 11 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.